mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.007 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.007 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.007 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.33 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.01 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |